Profil
Andrew Krishna Ekaputra is currently Senior Principal at EDB Investments Pte Ltd since 2023 and a Member of Tissue Engineering & Generative Medicine International Society.
Formerly, Dr. Ekaputra was Technical Director at Cordlife Group Ltd. Dr. Ekaputra completed undergraduate and doctorate degrees at the National University of Singapore, conferred in 2003 and 2010 respectively.
Aktiva positioner av Andrew Ekaputra
| Företag | Position | Start |
|---|---|---|
Tissue Engineering & Generative Medicine International Societ | Företagsledare/Principal | - |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDBI invests in companies located in Asia primarily in Singapore. The firm focuses on bio-based economy, green economy, next-generation hardware, mobility, health & wellness and digital economy sectors. It provides equity financing for later stage capital requirements. | Privat kapitalinvesterare | 2023-07-01 |
Tidigare kända positioner av Andrew Ekaputra
| Företag | Position | Slut |
|---|---|---|
| CORDLIFE GROUP LIMITED | Teknisk/Vetenskaplig/F&U Direktör | - |
Andrew Ekaputras utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EDB Investments Pte Ltd.
EDB Investments Pte Ltd. Investment ManagersFinance EDBI invests in companies located in Asia primarily in Singapore. The firm focuses on bio-based economy, green economy, next-generation hardware, mobility, health & wellness and digital economy sectors. It provides equity financing for later stage capital requirements. | Finance |
Cordlife Group Ltd.
Cordlife Group Ltd. Medical/Nursing ServicesHealth Services Provides cord blood banking services | Health Services |
Tissue Engineering & Generative Medicine International Societ |
















